340B Drug Pricing Program

E163275 UNEXPLORED

The 340B Drug Pricing Program is a U.S. federal initiative that requires drug manufacturers to provide outpatient medications to eligible healthcare organizations at significantly reduced prices to support care for underserved patients.

Referenced by (2)

Full triples — surface form annotated when it differs from this entity's canonical label.

Public Health Service Act → authorizes → 340B Drug Pricing Program →

Health Resources and Services Administration → oversees → 340B Drug Pricing Program →